Mariappan Paramananthan, Smith Gordon, Lamb Alastair D G, Grigor Kenneth M, Tolley David A
Department of Urology, Western General Hospital, Edinburgh, United Kingdom.
J Urol. 2007 Mar;177(3):867-75; discussion 875. doi: 10.1016/j.juro.2006.10.048.
Previously published data on the 25-year outcome of G1Ta and G2Ta bladder tumors demonstrated that both tumors have a similarly low risk of recurrence in cases in which no tumor was detected in the first 5 years after presentation. A further 4 prospectively maintained cohorts were available for comparison between institutions or across time periods.
Review of a prospectively kept, computerized record of patients with bladder cancer allowed analysis of the long-term outcome of 4 further cohorts of bladder cancer presenting in 1978 to 1986 or 1991 to 1996.
A total of 325 patients with G1Ta and 190 with G2Ta bladder tumors had up to 25 years of followup. The risk of recurrence in the first 5 years was identical in all cohorts from the 1980s. However, in those patients without recurrence in the initial 5 years, the subsequent risk of recurrence (in G1 and G2Ta tumors) was 3.2% in the earlier cohorts but increased 3-fold to 10.8% in the cohorts from the early 1990s (RR 3.3, 95% CI 1.2-9.5, p=0.016).
A difference was observed in the pattern of late biopsy proven recurrence in the more contemporary cases. Increased use of prophylactic intravesical chemotherapy does not seem to be a strong factor. Changes in the ability to detect lesions and the readiness to biopsy suspicious lesions may be responsible for this difference.
先前发表的关于G1Ta和G2Ta膀胱肿瘤25年转归的数据表明,在初诊后前5年未检测到肿瘤的病例中,这两种肿瘤的复发风险均同样较低。另外有4个前瞻性维持队列可用于机构间或不同时间段的比较。
回顾前瞻性保存的膀胱癌患者计算机记录,从而分析1978年至1986年或1991年至1996年出现的另外4个膀胱癌队列的长期转归。
共有325例G1Ta膀胱肿瘤患者和190例G2Ta膀胱肿瘤患者接受了长达25年的随访。20世纪80年代所有队列中,前5年的复发风险相同。然而,在最初5年未复发的患者中,后续复发风险(G1和G2Ta肿瘤)在早期队列中为3.2%,但在20世纪90年代早期的队列中增加了3倍,达到10.8%(相对危险度3.3,95%可信区间1.2 - 9.5,p = 0.016)。
在更现代病例中,观察到晚期活检证实的复发模式存在差异。预防性膀胱内化疗使用增加似乎并非一个重要因素。检测病变能力的变化以及对可疑病变进行活检的意愿可能是造成这种差异的原因。